正元智慧(300645.SZ)擬參設創業投資基金 主投TMT、大健康等項目
格隆匯4月14日丨正元智慧(300645.SZ)公佈,公司擬以自有資金參與設立私募創業投資基金,基金名稱為“杭州三葉草創業投資合夥企業(有限合夥)”(擬定名,最終名稱以工商登記機關最終核准的名稱為準),基金規模為人民幣2億元。其中,浙江華甌股權投資管理有限公司(“華甌投資”)作為普通合夥人、執行事務合夥人擬認繳出資人民幣460萬元,出資比例為2.30%;杭州高科技創業投資管理有限公司(“杭高投”)作為有限合夥人擬認繳出資人民幣3990萬元,出資比例為19.95%;公司作為有限合夥人擬認繳出資人民幣4000萬元,出資比例為20.00%;剩餘資金由其他投資人出資。基金投資方向:TMT、大健康、高端製造、網絡信息安全及現代服務業項目。
此次參與設立投資基金,旨在充分藉助專業投資機構的專業資源與投資管理優勢,實現公司產業和金融資本的良性互動,促進企業長遠發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.